The rapid transformation of cardiac surgery practice in the coronavirus disease 2019 (COVID-19) pandemic: insights and clinical strategies from a centre at the epicentre

被引：17

作者：

George, Isaac ^{[1
]}

Salna, Michael ^{[1
]}

Kobsa, Serge ^{[1
]}

Deroo, Scott ^{[1
]}

Kriegel, Jacob ^{[1
]}

Blitzer, David ^{[1
]}

Shea, Nicholas J. ^{[1
]}

D'Angelo, Alex ^{[1
]}

Raza, Tasnim ^{[1
]}

Kurlansky, Paul ^{[1
]}

Takeda, Koji ^{[1
]}

Takayama, Hiroo ^{[1
]}

Bapat, Vinayak ^{[1
]}

Naka, Yoshifumi ^{[1
]}

Smith, Craig R. ^{[1
]}

Bacha, Emile ^{[1
]}

Argenziano, Michael ^{[1
]}

机构：

[1] Columbia Univ, Irving Med Ctr, New York Presbyterian Hosp, Div Cardiac Thorac & Vasc Surg, New York, NY USA

来源：

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY | 2020年 / 58卷 / 04期

关键词：

Cardiac surgery; Coronavirus disease 2019; Pandemic; New York; Reorganization; ASSIST;

D O I：

10.1093/ejcts/ezaa228

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OBJECTIVES: The onset of the coronavirus disease 2019 (COVID-19) pandemic has forced our cardiac surgery programme and hospital to enact drastic measures that has forced us to change how we care for cardiac surgery patients, assist with COVID-19 care and enable support for the hospital in terms of physical resources, providers and resident training. METHODS: In this review, we review the cardiovascular manifestations of COVID-19 and describe our system-wide adaptations to the pandemic, including the use of telemedicine, how a severe reduction in operative volume affected our programme, the process of redeployment of staff, repurposing of residents into specific task teams, the creation of operation room intensive care units, and the challenges that we faced in this process. RESULTS: We offer a revised set of definitions of surgical priority during this pandemic and how this was applied to our system, followed by specific considerations in coronary/valve, aortic, heart failure and transplant surgery. Finally, we outline a path forward for cardiac surgery for the near future. CONCLUSIONS: We recognize that individual programmes around the world will eventually face COVID-19 with varying levels of infection burden and different resources, and we hope this document can assist programmes to plan for the future.

引用

页码：667 / 675

页数：9

共 18 条

[1]

[Anonymous], 2016, HAEMOST, DOI DOI 10.1111/JTH.13174

[2] Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality [J].

Bonow, Robert O. ;

Fonarow, Gregg C. ;

O'Gara, Patrick T. ;

Yancy, Clyde W. .

JAMA CARDIOLOGY, 2020, 5 (07) :751-753

[3]

Chau Vinh Q, 2020, JACC Case Rep, V2, P1315, DOI 10.1016/j.jaccas.2020.04.001

[4]

Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]

[5]

Corry DC, 1992, AM SOC ARTIF ORGANS, V44, pM347

[6]

Extracorporeal Life Support Organization, 2020, ELSO GUID DOC ECMO C

[7] Optimisation of air-distributor channel structural parameters based on Taguchi orthogonal design [J].

Feng, Guozeng ;

Lei, Shuya ;

Guo, Yuejiao ;

Shi, Dachuan ;

Shen, Jiu Bing .

CASE STUDIES IN THERMAL ENGINEERING, 2020, 21

[8] Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection [J].

Guo, Junyi ;

Huang, Zheng ;

Lin, Li ;

Lv, Jiagao .

JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (07)

[9]

Johns Hopkins University Coronavirus Resource Center, 2020, COVID 19 DASHB CTR S

[10]

Kollmar JP, 2017, A A CASE REP, V9, P77, DOI 10.1213/XAA.0000000000000531

← 1 2 →